A team of researchers from The University of Texas, Austin, has identified an antibody, ‘SC27’, that could potentially counteract all known variants of the virus causing COVID-19, as well as distantly related coronaviruses that infect animals. This finding marks a significant advancement in the ongoing efforts to manage the COVID-19 pandemic. Antibody ‘SC27’ Shows Promise … Read more
San Diego: A method for finding high-affinity antibody therapeutics that is based on artificial intelligence (AI) has been created by researchers at the University of California San Diego School of Medicine. In the findings of the study published in Nature Communications, researchers used the approach to identify a new antibody that binds a major cancer … Read more
A large study has begun to find out whether nirsevimab should be offered to all babies in the UK. Source link
The antibody injection had promised a protection boost to those with conditions such as blood cancer. Source link
By Amy Norton HealthDay Reporter THURSDAY, Aug. 4, 2022 (HealthDay News) — Researchers are reporting early but encouraging findings on a potential new way to prevent malaria — an old foe that still ranks as a major killer worldwide. In a small trial of healthy volunteers, U.S. government researchers found that a lab-engineered antibody protected … Read more
June 8, 2022 — Take that, Omicron. Results of a trial looking at a combination COVID-19 vaccine booster reveals a “robust antibody response” against the Omicron variant, vaccine manufacturer Moderna announced Wednesday. The neutralizing antibody response was eight times greater at 1 month following a 50-mcg dose with the booster containing both the original mRNA-1273 … Read more
Henny Braund, chief executive of cancer charity Anthony Nolan, said: “This is positive news for blood cancer patients, who we know are less likely to be protected from Covid-19 vaccines than the wider population. It is particularly important that patients can access this treatment immediately, if they contract the virus, and there is clear guidance … Read more
Lanson Jones, Houston. Howard Huang, MD, pulmonologist, Houston Methodist Hospital. Amesh Adalja, MD, emerging infectious diseases specialist, Johns Hopkins University Center for Health Security. Terry Scoggin, CEO, Titus Regional Medical Center, Mount Pleasant, TX. Frederick Thurmond, MD, hospitalist, Titus Regional Medical Center. Seth Thurman, Mount Pleasant, TX. Whitehouse.gov: “Remarks by President Biden … Read more
Sept. 22, 2021 — At least two states are recommending that doctors prioritize the limited supply of monoclonal antibody treatments for high-risk COVID-19 patients, including unvaccinated people who face severe disease. Tennessee health officials say that nearly all vaccinated patients should receive lower priority to preserve supplies for those who remain most vulnerable, while … Read more
The UK-wide scheme for adults who test positive for coronavirus will launch next week. Source link